Skip to main content
NovartisProduct change

Novartis has discontinued its Amyotrophic Lateral Sclerosis (ALS) program following a failure in its phase 2 clinical trial, adding to its R&D challenges.

What happened

Post: "Novartis ends ALS program after phase 2 flop, adding to R&D woes"

Source

Comments on the post

  • “Oh Giovanni! You failed BMS and now you fail Novartis! Talk about failing up!”

    u/OrangeNo22551 points · Sep 20, 2026View

Extracted by Autobound

From the Signal API record
Signal
Product change

What this signalsUser posts often show product pain before it reaches reviews or churn.

Subreddit
r/biotech
Stage
Confirmed
Event date
Sep 2026

The full record

From the Signal API record

Numbers

Mentions
2

Details

Timing
Completed
Category
Discontinued
Virality
Medium
Post kind
Link
Prominence
Core
Company's role
Subject
Signal category
Event

Topics and mentions

Topics

  • clinical trials
  • drug development
  • r&d
  • pharma
  • als

Flair

  • Biotech News 📰

Extraction

Sentiment
Negative
Detected
Sep 16, 2026
signal_type
reddit-company
signal_subtype
productChange

Use this data

Get every Reddit signal for Novartis and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Novartis this week?”

  2. Send it to your own tools

    The Signal API returns Reddit signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full reddit-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/caf7e8d8-3703-5569-afd3-67b5c8890989 returns this record as JSON. POST /v1/companies/enrich returns every signal for novartis.com.

{
  "signal_id": "caf7e8d8-3703-5569-afd3-67b5c8890989",
  "signal_type": "reddit-company",
  "signal_subtype": "productChange",
  "detected_at": "2026-09-16T14:53:57+00:00",
  "company": {
    "name": "Novartis",
    "domain": "novartis.com"
  },
  "data": {
    "nsfw": false,
    "stage": "confirmed",
    "awards": 0,
    "timing": "completed",
    "topics": [
      "r&d",
      "clinical trials",
      "drug development",
      "pharma",
      "als"
    ],
    "post_id": "1whzhyv",
    "summary": "Novartis has discontinued its Amyotrophic Lateral Sclerosis (ALS) program following a failure in its phase 2 clinical trial, adding to its R&D challenges.",
    "category": "discontinued",
    "comments": [
      {
        "url": "https://www.reddit.com/r/biotech/comments/1whzhyv/comment/pav5m2o/",
        "depth": 0,
        "score": 1,
        "author": "OrangeNo2255",
        "excerpt": "Oh Giovanni! You failed BMS and now you fail Novartis! Talk about failing up!",
        "posted_at": "2026-09-20T00:01:11.000Z",
        "author_url": "https://www.reddit.com/user/OrangeNo2255/"
      }
    ],
    "evidence": [
      "[post] Novartis ends ALS program after phase 2 flop, adding to R&D woes",
      "[comment u/OrangeNo2255] Oh Giovanni! You failed BMS and now you fail Novartis! Talk about failing up!"
    ],
    "link_url": "https://www.fiercebiotech.com/biotech/novartis-ends-als-program-after-phase-2-flop-adding-rd-woes",
    "virality": "medium",
    "post_date": "2026-09-16T14:53:57.000Z",
    "post_kind": "link",
    "sentiment": "negative",
    "subreddit": "biotech",
    "event_date": "2026-09",
    "post_flair": [
      "Biotech News 📰"
    ],
    "post_title": "Novartis ends ALS program after phase 2 flop, adding to R&D woes",
    "prominence": "core",
    "source_url": "https://www.reddit.com/r/biotech/comments/1whzhyv/novartis_ends_als_program_after_phase_2_flop/",
    "entity_role": "subject",
    "post_author": "NotGenentech",
    "upvote_ratio": 1,
    "mention_count": 2,
    "mention_surge": false,
    "subreddit_url": "https://www.reddit.com/r/biotech/",
    "total_upvotes": 56,
    "comments_total": 1,
    "total_comments": 1,
    "post_author_url": "https://www.reddit.com/user/NotGenentech/",
    "signal_category": "event",
    "comments_included": 1
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.